 | Up a level |
Jain, Tania; Estrada-Merly, Noel; Salas, M Queralt; Kim, Soyoung; DeVos, Jakob D; Chen, Min; Fang, Xi; Kumar, Rajat; Andrade-Campos, Marcio; Elmariah, Hany; Agrawal, Vaibhav; Aljurf, Mahmoud; Bacher, Ulrike; Badar, Talha; Badawy, Sherif M; Ballen, Karen Kuhn; Beitinjaneh, Amer; Bhatt, Vijaya R; Bredeson, Christopher N; DeFilipp, Zachariah; ... (2024). Donor Types and Outcomes of Transplantation in Myelofibrosis: A CIBMTR Study. Blood advances, 8(16), pp. 4281-4293. American Society of Hematology 10.1182/bloodadvances.2024013451
Codilupi, Tamara; Szybinski, Jakub; Arunasalam, Stefanie; Jungius, Sarah; Dunbar, Andrew C; Stivala, Simona; Brkic, Sime; Albrecht, Camille; Vokalova, Lenka; Yang, Julie L; Buczak, Katarzyna; Ghosh, Nilabh; Passweg, Jakob R; Rovo, Alicia; Angelillo-Scherrer, Anne; Pankov, Dmitry; Dirnhofer, Stephan; Levine, Ross L; Koche, Richard and Meyer, Sara C (2024). Development of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable. Clinical cancer research, 30(3), pp. 586-599. American Association for Cancer Research 10.1158/1078-0432.CCR-23-0163
Schifferli, Alexandra; Rüfer, Axel; Rovo, Alicia; Nimmerjahn, Falk; Cantoni, Nathan; Holbro, Andreas; Favre, Geneviève; Dirks, Jan; Wieland, Anna; Faeth, Heike; Pereira, Renata; Kühne, Thomas (2023). Immunomodulation with romiplostim as a second-line strategy in primary immune thrombocytopenia: The iROM study. British journal of haematology, 203(1), pp. 119-130. Wiley-Blackwell 10.1111/bjh.19074
